Omeros reported $627K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US $ 0.15M 0.01M
Adma Biologics ADMA:US $ 0.02M 0M
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Gilead Sciences GILD:US $ 1M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.19M 6K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Knight Therapeutics Inc GUD:CN C$ 619.67M 9.18M
Macrogenics MGNX:US $ 0.61M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Omeros OMER:US $ 627K 1000
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Regulus Therapeutics RGLS:US $ 0.15M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 86K 1000